Mesocortical BDNF signaling mediates antidepressive-like effects of lithium
- 1 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 45 (9), 1557-1566
- https://doi.org/10.1038/s41386-020-0713-0
Abstract
Lithium has been used to treat major depressive disorder, yet the neural circuit mechanisms underlying this therapeutic effect remain unknown. Here, we demonstrated that the ventral tegmental area (VTA) dopamine (DA) neurons that project to the medial prefrontal cortex (mPFC), but not to nucleus accumbens (NAc), contributed to the antidepressive-like effects of lithium. Projection-specific electrophysiological recordings revealed that high concentrations of lithium increased firing rates in mPFC-, but not NAc-, projecting VTA DA neurons in mice treated with chronic unpredictable mild stress (CMS). In parallel, chronic administration of high-dose lithium in CMS mice restored the firing properties of mPFC-projecting DA neurons, and also rescued CMS-induced depressive-like behaviors. Nevertheless, chronic lithium treatment was insufficient to change the basal firing rates in NAc-projecting VTA DA neurons. Furthermore, chemogenetic activation of mPFC-, but not NAc-, projecting VTA DA neurons mimicked the antidepressive-like effects of lithium in CMS mice. Chemogenetic downregulation of VTA-mPFC DA neurons' firing activity abolished the antidepressive-like effects of lithium in CMS mice. Finally, we found that the antidepressant-like effects induced by high-dose lithium were mediated by BNDF signaling in the mesocortical DA circuit. Together, these results demonstrated the role of mesocortical DA projection in antidepressive-like effects of lithium and established a circuit foundation for lithium-based antidepressive treatment.This publication has 77 references indexed in Scilit:
- Different stressors produce excitation or inhibition of mesolimbic dopamine neuron activity: response alteration by stress pre‐exposureEuropean Journal of Neuroscience, 2012
- Selective DNA Methylation of BDNF Promoter in Bipolar Disorder: Differences Among Patients with BDI and BDIINeuropsychopharmacology, 2012
- GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food IntakeEndocrinology, 2012
- Projection-Specific Modulation of Dopamine Neuron Synapses by Aversive and Rewarding StimuliNeuron, 2011
- Specific Role of VTA Dopamine Neuronal Firing Rates and Morphology in the Reversal of Anxiety-Related, but not Depression-Related Behavior in the ClockΔ19 Mouse Model of ManiaNeuropsychopharmacology, 2011
- Aversive Stimuli Alter Ventral Tegmental Area Dopamine Neuron Activity via a Common Action in the Ventral HippocampusJournal of Neuroscience, 2011
- Mesolimbic Dopamine Neurons in the Brain Reward Circuit Mediate Susceptibility to Social Defeat and Antidepressant ActionJournal of Neuroscience, 2010
- Cell Type–Specific Loss of BDNF Signaling Mimics Optogenetic Control of Cocaine RewardScience, 2010
- Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?Neuropsychopharmacology, 2010
- New insights into BDNF function in depression and anxietyNature Neuroscience, 2007